News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Norwood Abbey Limited Presents Half-Year Results And Summary Of Operations


10/19/2005 5:12:53 PM

MELBOURNE, Australia--(BUSINESS WIRE)--March 1, 2005--Norwood Abbey Limited (Other-OTC:NABYF) (ASX:NAL): Highlights: -- Board of Directors re-structured with three U.S.-based appointments -- EyeCare infrastructure developed; sales/marketing program commences worldwide -- Laser Assisted Drug Delivery (LAD) pediatric hospital sales/marketing program continues -- Needle-free drug delivery product development progresses; chemical mulesing solution with Australian Wool Innovations Ltd. (AWI) a priority -- Immunology receives U.S. FDA acceptance of Investigational New Drug (IND) application for first U.S.-based clinical trial, supported by consortium of leading cancer specialists, co-funded by the U.S. National Cancer Institute and the National Institute of Allergy and Infectious Diseases

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES